Your browser doesn't support javascript.
loading
Systematic analysis of levels of evidence supporting American Academy of Ophthalmology Preferred Practice Pattern guidelines, 2012-2021.
Song, Ailin; Lusk, Jay B; Kuo, Anthony N; Muir, Kelly W; Stinnett, Sandra S; Borkar, Durga S.
Afiliación
  • Song A; Duke University School of Medicine, Durham, NC, 27705, USA.
  • Lusk JB; Duke University School of Medicine, Durham, NC, 27705, USA.
  • Kuo AN; Duke University School of Medicine, Durham, NC, 27705, USA.
  • Muir KW; Duke University Eye Center, Durham, NC, USA.
  • Stinnett SS; Duke University School of Medicine, Durham, NC, 27705, USA.
  • Borkar DS; Duke University Eye Center, Durham, NC, USA.
BMC Ophthalmol ; 23(1): 132, 2023 Mar 31.
Article en En | MEDLINE | ID: mdl-37004018
ABSTRACT

BACKGROUND:

Despite the increased emphasis on evidence-based medicine, the current state of evidence behind ophthalmology clinical practice guidelines is unknown. The purpose of this systematic analysis was to understand the levels of evidence (LOE) supporting American Academy of Ophthalmology (AAO) Preferred Practice Pattern (PPP) guidelines, assess changes over time, and compare LOE across ophthalmology subspecialties.

METHODS:

All current PPP guidelines and their immediate predecessors were comprehensively reviewed to identify all recommendations with LOE provided (I [randomized controlled trials], II [case-control or cohort studies], and III [nonanalytic studies]).

RESULTS:

Twenty-three out of 24 current PPPs had a prior edition. Among the PPPs with a prior edition, the number of recommendations with LOE decreased from 1254 in prior PPPs to 94 in current PPPs. The number of recommendations with LOE I decreased from 114 to 83, LOE II decreased from 147 to 2, and LOE III decreased from 993 to 9. However, the proportion of LOE I recommendations increased from 9 to 88%, driven by a disproportionate decrease in reporting of evidence lower than LOE I. Subgroup analysis by subspecialty showed similar trends (LOE I recommendations in prior PPPs vs current PPPs retina 57 [12%] vs 19 [100%]; cornea 33 [5%] vs 24 [100%]; glaucoma 9 [23%] vs 17 [100%]; cataract 13 [17%] vs 18 [100%]).

CONCLUSIONS:

Trends in LOE reporting in PPP guidelines indicate an increasing emphasis on evidence from randomized controlled trials from 2012 to 2021. The decline in the number of recommendations with LOE reported suggests an area for improvement in future guidelines as the presence of LOE is crucial to facilitate interpretation of clinical practice guidelines.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oftalmología / Catarata Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: BMC Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oftalmología / Catarata Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: BMC Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos